Reuters report cited by Mylan executive chairman in letter to Teva CEO - Reuters News Agency
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
US Supreme Court sides with Teva in drug dispute
Averting opioid trial, Teva, drug distributors reach last-gasp settlement - The Jerusalem Post
Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters
Israeli drug giant Teva stock price stutters as legal cloud darkens - Business - Haaretz.com
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid
Teva fueled opioid addiction in New York, jury finds By Reuters - Country Highlights
New branded drugs helping Teva Pharm move closer to growth | Reuters.com
Oklahoma Reaches $85 Million Settlement With Teva Pharmaceuticals Ahead of Trial
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | FiercePharma
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharm's chairman Phillip Frost to step down by year end
GSK's $235 million verdict revived against Teva, again | Reuters
Teva profit rise misses forecasts, sees lower 2021 sales | Reuters
Teva stock plummets 18% after rough quarter in US generic drug market
Matko Bolanca, the new chief executive of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries, poses in his Zagreb office March 18, 2010. Pliva was Croatia's biggest drugs firm in the
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
U.S. settles with Teva over keeping generic drugs off market - The Jerusalem Post
Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in the central Israeli town of Shoham March 1, 2011. Teva Pharmaceutical Industries, the world's largest generics
Teva Pharmaceutical set for major layoffs in Israel, U.S.: report | Reuters
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Reuters: Teva to pay US government $519 million over foreign bribery charges - Dec. 22, 2016 | KyivPost | KyivPost - Ukraine's Global Voice
Teva shares plunge after drugmaker misses revenue forecasts
